Neue Suche
Prof. Dr. Jörn Stitz
Kontaktdaten
E-Mail:
joern.stitz@th-koeln.de
Webseite:
Publikationen:
Forschungsschwerpunkte
Als Autor*in:
- HIV-Gag VLP-based Vaccine Purification at Manufacturing scale
- Development of Lentiviral Packaging Cells and Scale Up of Production to Meet the Growing Demand in Cell and Gene Therapy
- Digital Twin for Upstream and Downstream Integration of Virus-like Particle Manufacturing
- Optimizing Nuclease Treatment to Enhance Anion Exchange Chromatography of HIV-Derived Virus-Like Particles
- Platform Process for an Autonomous Production of Virus-like Particles
- Development of HIV-1 Vectors Pseudotyped with Envelope Proteins of other Retroviruses
- Digital Twin for Continuous Production of Virus-like Particles toward Autonomous Operation
- Investigation of the Electrokinetic Properties of HIV-Based Virus-Like Particles
- The Effects of High Shear Rates on the Average Hydrodynamic Diameter Measured in Biomimetic HIV Gag Virus-Like Particle Dispersions
- Generation of Antibodies Selectively Recognizing Epitopes in a Formaldehyde-Fixed Cell-Surface Antigen Using Virus-like Particle Display and Hybridoma Technology
- Generation of Human 293-F Suspension NGFR Knockout Cells Using CRISPR/Cas9 Coupled to Fluorescent Protein Expression
- Novel Suspension Retroviral Packaging Cells Generated by Transposition Using Transposase Encoding mRNA Advance Vector Yields and Enable Production in Bioreactors
- Production of Retroviral Vectors in Continuous High Cell Density Culture
- A Hydrodynamic Approach to the Study of HIV Virus-Like Particle (VLP) Tangential Flow Filtration
- Components of a HIV-1 Vaccine Mediate Virus-like Particle (VLP)-Formation and Display of Envelope Proteins Exposing Broadly Neutralizing Epitopes
- Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
- Digital Twin for HIV-Gag VLP Production in HEK293 Cells
- Ecotropic HIV-1 Vectors Pseudotyped with R-Peptide-Deleted Envelope Protein Variants Reveal Improved Gene Transfer Efficiencies
- Infectious RNA
- Process Design and Optimization towards Digital Twins for HIV-Gag VLP Production in HEK293 Cells, including Purification
- Towards Autonomous Process Control—Digital Twin for HIV-Gag VLP Production in HEK293 Cells Using a Dynamic Metabolic Model
- Transgene Expression and Transposition Efficiency of Two-Component Sleeping Beauty Transposon Vector Systems Utilizing Plasmid or mRNA Encoding the Transposase
- Establishment of a Novel Stable Human Suspension Packaging Cell line Producing Ecotropic Retroviral MLV(PVC-211) Vectors Efficiently Transducing Murine Hematopoietic Stem and Progenitor Cells
- Advanced Establishment of Stable Recombinant Human Suspension Cell Lines Using Genotype-Phenotype Coupling Transposon Vectors
- Transposon Vector-mediated Stable Gene Transfer for the Accelerated Establishment of Recombinant Mammalian Cell Pools Allowing for High-yield Production of Biologics
- Rapid Establishment of Stable Retroviral Packaging Cells and Recombinant Susceptible Target Cell Lines Employing Novel Transposon Vectors Derived from Sleeping Beauty
- Displaying Tetra-Membrane Spanning Claudins on Enveloped Virus-Like Particles for Cancer Immunotherapy
- Functional Characterization of the Mouse Serpina1 Paralog DOM-7
- Herstellung der nächsten Generation viraler Impfstoffe
- Envelope Proteins of Spleen Necrosis Virus form Infectious Human Immunodeficiency Virus type 1 Pseudotype Vector Particles, but Fail to Incorporate Upon Substitution of the Cytoplasmic Domain with that of Gibbon Ape Leukemia Virus
- Fusoselect: Cell-cell fusion activity engineered by directed evolution of a retroviral glycoprotein
- Retroviral Vectors for Vaccine Development: Induction of HIV-1-Specific Humoral and Cellular Immune Responses in Rhesus Macaques Using a Novel MLV(HIV-1) Pseudotype Vector
- Directed Evolution of Retrovirus Envelope Protein Cytoplasmic Tails Guided by Functional Incorporation into Lentivirus Particles
- Screening of Retroviral cDNA Libraries for Factors Involved in Protein Phosphorylation in Signaling Cascades
- Genetic Engineering of Onco/Lentivirus Hybrids Results in Formation of Infectious but not of Replication-Competent Viruses
- Targeting Human T Cells by Retroviral Vectors Displaying Antibody Domains Selected from a Phage Display Library
- Transduction Efficiency of MLV but not of HIV-1 Vectors is Pseudotype Dependent on Human Primary T Lymphocytes
- A Novel Lentivirus Vector Derived from Apathogenic Simian Immunodeficiency Virus
- Coreceptor Switch of [MLV(SIVagm)] Pseudotype Vectors by V3-Loop Exchange
- Identification of R-peptides in Envelope Proteins of C-type Retroviruses
- Targeted Gene Transfer to Lymphocytes Using Murine Leukaemia Virus Vectors Pseudotyped with Spleen Necrosis Virus Envelope Proteins
- Lentiviral Vectors Pseudotyped with Envelope Glycoproteins Derived from Gibbon Ape Leukemia Virus and Murine Leukemia Virus 10A1
- MLV-Derived Retroviral Vectors Selective for CD4-Expressing Cells and Resistant to Neutralization by Sera from HIV-Infected Patients
- Retroviral Cell Targeting Vectors
- High-Titer Retroviral Pseudotype Vectors for Specific Targeting of Human CD4-Positive Cells
- Pseudotyping of Murine Leukemia Virus with the Envelope Glycoproteins of HIV Generates a Retroviral Vector with Specificity of Infection for CD4- Expressing Cells
- Inhibition of HIV-1 Replication via Antisense Oligonucleotides
Publikationsliste
Publikationsliste (CSV)
Publikationsliste (PDF) im "American Psychological Association 6th edition (DOI)"-Zitierstil
Publikationsliste (PDF) im "Anglia Ruskin University - Harvard"-Zitierstil
Publikationsliste (PDF) im "Gesellschaft für Bildung und Forschung in Europa - Harvard"-Zitierstil
Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format
Als Autor*in::
- HIV-Gag VLP-based Vaccine Purification at Manufacturing scale
- Development of Lentiviral Packaging Cells and Scale Up of Production to Meet the Growing Demand in Cell and Gene Therapy
- Digital Twin for Upstream and Downstream Integration of Virus-like Particle Manufacturing
- Optimizing Nuclease Treatment to Enhance Anion Exchange Chromatography of HIV-Derived Virus-Like Particles
- Platform Process for an Autonomous Production of Virus-like Particles
- Development of HIV-1 Vectors Pseudotyped with Envelope Proteins of other Retroviruses
- Digital Twin for Continuous Production of Virus-like Particles toward Autonomous Operation
- Investigation of the Electrokinetic Properties of HIV-Based Virus-Like Particles
- The Effects of High Shear Rates on the Average Hydrodynamic Diameter Measured in Biomimetic HIV Gag Virus-Like Particle Dispersions
- Generation of Antibodies Selectively Recognizing Epitopes in a Formaldehyde-Fixed Cell-Surface Antigen Using Virus-like Particle Display and Hybridoma Technology
- Generation of Human 293-F Suspension NGFR Knockout Cells Using CRISPR/Cas9 Coupled to Fluorescent Protein Expression
- Novel Suspension Retroviral Packaging Cells Generated by Transposition Using Transposase Encoding mRNA Advance Vector Yields and Enable Production in Bioreactors
- Production of Retroviral Vectors in Continuous High Cell Density Culture
- A Hydrodynamic Approach to the Study of HIV Virus-Like Particle (VLP) Tangential Flow Filtration
- Components of a HIV-1 Vaccine Mediate Virus-like Particle (VLP)-Formation and Display of Envelope Proteins Exposing Broadly Neutralizing Epitopes
- Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
- Digital Twin for HIV-Gag VLP Production in HEK293 Cells
- Ecotropic HIV-1 Vectors Pseudotyped with R-Peptide-Deleted Envelope Protein Variants Reveal Improved Gene Transfer Efficiencies
- Infectious RNA
- Process Design and Optimization towards Digital Twins for HIV-Gag VLP Production in HEK293 Cells, including Purification
- Towards Autonomous Process Control—Digital Twin for HIV-Gag VLP Production in HEK293 Cells Using a Dynamic Metabolic Model
- Transgene Expression and Transposition Efficiency of Two-Component Sleeping Beauty Transposon Vector Systems Utilizing Plasmid or mRNA Encoding the Transposase
- Establishment of a Novel Stable Human Suspension Packaging Cell line Producing Ecotropic Retroviral MLV(PVC-211) Vectors Efficiently Transducing Murine Hematopoietic Stem and Progenitor Cells
- Advanced Establishment of Stable Recombinant Human Suspension Cell Lines Using Genotype-Phenotype Coupling Transposon Vectors
- Transposon Vector-mediated Stable Gene Transfer for the Accelerated Establishment of Recombinant Mammalian Cell Pools Allowing for High-yield Production of Biologics
- Rapid Establishment of Stable Retroviral Packaging Cells and Recombinant Susceptible Target Cell Lines Employing Novel Transposon Vectors Derived from Sleeping Beauty
- Displaying Tetra-Membrane Spanning Claudins on Enveloped Virus-Like Particles for Cancer Immunotherapy
- Functional Characterization of the Mouse Serpina1 Paralog DOM-7
- Herstellung der nächsten Generation viraler Impfstoffe
- Envelope Proteins of Spleen Necrosis Virus form Infectious Human Immunodeficiency Virus type 1 Pseudotype Vector Particles, but Fail to Incorporate Upon Substitution of the Cytoplasmic Domain with that of Gibbon Ape Leukemia Virus
- Fusoselect: Cell-cell fusion activity engineered by directed evolution of a retroviral glycoprotein
- Retroviral Vectors for Vaccine Development: Induction of HIV-1-Specific Humoral and Cellular Immune Responses in Rhesus Macaques Using a Novel MLV(HIV-1) Pseudotype Vector
- Directed Evolution of Retrovirus Envelope Protein Cytoplasmic Tails Guided by Functional Incorporation into Lentivirus Particles
- Screening of Retroviral cDNA Libraries for Factors Involved in Protein Phosphorylation in Signaling Cascades
- Genetic Engineering of Onco/Lentivirus Hybrids Results in Formation of Infectious but not of Replication-Competent Viruses
- Targeting Human T Cells by Retroviral Vectors Displaying Antibody Domains Selected from a Phage Display Library
- Transduction Efficiency of MLV but not of HIV-1 Vectors is Pseudotype Dependent on Human Primary T Lymphocytes
- A Novel Lentivirus Vector Derived from Apathogenic Simian Immunodeficiency Virus
- Coreceptor Switch of [MLV(SIVagm)] Pseudotype Vectors by V3-Loop Exchange
- Identification of R-peptides in Envelope Proteins of C-type Retroviruses
- Targeted Gene Transfer to Lymphocytes Using Murine Leukaemia Virus Vectors Pseudotyped with Spleen Necrosis Virus Envelope Proteins
- Lentiviral Vectors Pseudotyped with Envelope Glycoproteins Derived from Gibbon Ape Leukemia Virus and Murine Leukemia Virus 10A1
- MLV-Derived Retroviral Vectors Selective for CD4-Expressing Cells and Resistant to Neutralization by Sera from HIV-Infected Patients
- Retroviral Cell Targeting Vectors
- High-Titer Retroviral Pseudotype Vectors for Specific Targeting of Human CD4-Positive Cells
- Pseudotyping of Murine Leukemia Virus with the Envelope Glycoproteins of HIV Generates a Retroviral Vector with Specificity of Infection for CD4- Expressing Cells
- Inhibition of HIV-1 Replication via Antisense Oligonucleotides
Publikationsliste
Publikationsliste (CSV)
Publikationsliste (PDF) im "American Psychological Association 6th edition (DOI)"-Zitierstil
Publikationsliste (PDF) im "Anglia Ruskin University - Harvard"-Zitierstil
Publikationsliste (PDF) im "Gesellschaft für Bildung und Forschung in Europa - Harvard"-Zitierstil
Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format